Arcus Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Arcus Biosciences
RCUS Stock  USD 23.29  0.54  2.27%   
Arcus Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Arcus Biosciences' valuation are provided below:
Gross Profit
-263 M
Profit Margin
(1.42)
Market Capitalization
2.9 B
Enterprise Value Revenue
9.2852
Revenue
240 M
There are over one hundred nineteen available fundamental signals for Arcus Biosciences, which can be analyzed over time and compared to other ratios. All traders should validate Arcus Biosciences' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 2.7 B in 2026. Enterprise Value is likely to gain to about 2.6 B in 2026

Arcus Biosciences Total Revenue

311.54 Million

Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 58 M, Interest Income of 62.8 M or Depreciation And Amortization of 12.1 M, as well as many indicators such as Price To Sales Ratio of 5.68, Dividend Yield of 0.0 or PTB Ratio of 3.11. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Arcus Stock
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Arcus Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets822.9 M1.3 B560.9 M
Slightly volatile
Other Current Liabilities132.8 M126.5 M36.3 M
Slightly volatile
Total Current Liabilities272.9 M259.9 M89.1 M
Slightly volatile
Total Stockholder Equity440 M557.8 M305.6 M
Slightly volatile
Other Liabilities456.4 M434.7 M160.1 M
Slightly volatile
Property Plant And Equipment Net53.1 M54 M34.9 M
Slightly volatile
Accounts Payable11.8 M20.7 M8.9 M
Slightly volatile
Cash134.1 M172.5 M105.6 M
Slightly volatile
Non Current Assets Total133.7 M154.1 M84.8 M
Slightly volatile
Non Currrent Assets Other88.1 M84 M22.4 M
Slightly volatile
Other Assets8.5 M16.1 M6.4 M
Slightly volatile
Cash And Short Term Investments573.6 M1.1 B410.9 M
Slightly volatile
Net Receivables27.3 M28.8 M54 M
Pretty Stable
Common Stock Shares Outstanding60.2 M103.6 M47.3 M
Slightly volatile
Short Term Investments999.8 M952.2 M338.3 M
Slightly volatile
Liabilities And Stockholders Equity822.9 M1.3 B560.9 M
Slightly volatile
Non Current Liabilities Total266.9 M504.9 M175.5 M
Slightly volatile
Capital Surpluse1.4 B1.3 B509.9 M
Slightly volatile
Other Current Assets10.5 M14.9 M6.7 M
Slightly volatile
Total Liabilities382.9 M764.8 M255.4 M
Slightly volatile
Property Plant And Equipment Gross53.1 M101.2 M37.7 M
Slightly volatile
Preferred Stock Total Equity190.1 M260.1 M182.1 M
Slightly volatile
Total Current Assets689.2 M1.2 B476.1 M
Slightly volatile
Non Current Liabilities Other143.6 M180.6 M88.2 M
Slightly volatile
Common Stock2 B1.9 B467.4 M
Slightly volatile
Property Plant Equipment163 M155.2 M50.5 M
Slightly volatile
Current Deferred Revenue64.3 M97.8 M39.1 M
Slightly volatile
Common Stock Total Equity5.3 K8.1 K4.7 K
Slightly volatile
Deferred Long Term Liabilities2.6 M2.7 M4.1 M
Pretty Stable
Net Invested Capital487.9 M613 M336.8 M
Slightly volatile
Net Working Capital632.1 M908.5 M428.6 M
Slightly volatile
Short Term Debt7.2 M13.8 M5.6 M
Slightly volatile
Capital Stock2 B1.9 B467.4 M
Slightly volatile
Short and Long Term Debt Total53 M54 M36.4 M
Slightly volatile
Capital Lease Obligations10.3 M10.8 M19.5 M
Very volatile
Long Term Debt38.4 M43.2 M47.2 M
Slightly volatile

Arcus Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income58 M55.2 M13.4 M
Slightly volatile
Interest Income62.8 M59.8 M14.4 M
Slightly volatile
Depreciation And Amortization12.1 M11.5 M4.3 M
Slightly volatile
Selling General Administrative144.9 M138 M47.8 M
Slightly volatile
Other Operating Expenses710 M676.2 M217.8 M
Slightly volatile
Research Development541 M515.2 M166.1 M
Slightly volatile
Cost Of Revenue10.9 M11.5 M40.7 M
Slightly volatile
Total Operating Expenses710 M676.2 M217.8 M
Slightly volatile
Total Other Income Expense Net56.8 M54 M13.2 M
Slightly volatile
Reconciled Depreciation5.8 M11.5 M4.6 M
Slightly volatile
Non Operating Income Net Other339.4 K357.3 K3.2 M
Slightly volatile
Selling And Marketing Expenses13.6 M15.3 M16.7 M
Slightly volatile

Arcus Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation91.8 M87.4 M28.5 M
Slightly volatile
Begin Period Cash Flow122.3 M149.5 M91.4 M
Slightly volatile
Other Cashflows From Financing Activities1.7 M1.8 M39.2 M
Slightly volatile
Depreciation6.3 M11.5 M4.5 M
Slightly volatile
Capital Expenditures9.8 M6.9 M7.2 M
Slightly volatile
Change To Operating Activities27.8 M26.4 M9.6 M
Slightly volatile
Total Cash From Financing Activities162.2 M318.6 M131.1 M
Slightly volatile
End Period Cash Flow135.2 M175.9 M106.4 M
Slightly volatile
Change To Netincome91.8 M87.4 M29.3 M
Slightly volatile
Issuance Of Capital Stock122 M205.2 M140.9 M
Pretty Stable
Dividends Paid4 M4.5 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.685.98147
Slightly volatile
PTB Ratio3.113.183.3487
Slightly volatile
Days Sales Outstanding30.2431.8367.3549
Slightly volatile
Book Value Per Share5.594.845.7429
Slightly volatile
Stock Based Compensation To Revenue0.340.270.3764
Very volatile
Capex To Depreciation0.510.542.1101
Slightly volatile
PB Ratio3.113.183.3487
Slightly volatile
EV To Sales5.35.58114
Slightly volatile
Payables Turnover0.360.50.4519
Slightly volatile
Sales General And Administrative To Revenue0.510.532.9516
Slightly volatile
Research And Ddevelopement To Revenue1.92.017.1961
Slightly volatile
Capex To Revenue0.02540.02671.8994
Slightly volatile
Cash Per Share6.989.777.0253
Slightly volatile
Days Payables Outstanding8599671.1 K
Slightly volatile
Current Ratio9.825.1711.9516
Slightly volatile
Tangible Book Value Per Share5.594.845.7429
Slightly volatile
Receivables Turnover11.2711.8744.2198
Slightly volatile
Shareholders Equity Per Share5.594.845.7429
Slightly volatile
Debt To Equity0.07990.110.0584
Slightly volatile
Capex Per Share0.05690.05990.156
Pretty Stable
Revenue Per Share1.362.581.0548
Slightly volatile
Interest Debt Per Share1.00.820.538
Slightly volatile
Debt To Assets0.03910.0470.0311
Slightly volatile
Graham Number11.5613.014.1905
Slightly volatile
Operating Cycle30.2431.8367.3549
Slightly volatile
Price Book Value Ratio3.113.183.3487
Slightly volatile
Days Of Payables Outstanding8599671.1 K
Slightly volatile
Ebt Per Ebit1.050.990.9714
Pretty Stable
Company Equity Multiplier1.332.131.4733
Slightly volatile
Long Term Debt To Capitalization0.07210.08110.0885
Slightly volatile
Total Debt To Capitalization0.07020.09910.0531
Slightly volatile
Debt Equity Ratio0.07990.110.0584
Slightly volatile
Quick Ratio4.915.1711.9852
Slightly volatile
Net Income Per E B T0.80.920.9604
Pretty Stable
Cash Ratio0.730.766.056
Slightly volatile
Days Of Sales Outstanding30.2431.8367.3549
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.21.191.1824
Slightly volatile
Price To Book Ratio3.113.183.3487
Slightly volatile
Fixed Asset Turnover5.194.941.7984
Slightly volatile
Debt Ratio0.03910.0470.0311
Slightly volatile
Price Sales Ratio5.685.98147
Slightly volatile
Asset Turnover0.210.20.0782
Slightly volatile
Price Fair Value3.113.183.3487
Slightly volatile

Arcus Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.7 B2.5 B1.3 B
Slightly volatile
Enterprise Value2.6 B2.5 B1.2 B
Slightly volatile

Arcus Fundamental Market Drivers

Arcus Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue97.8 M64.3 M
Total Revenue296.7 M311.5 M
Cost Of Revenue11.5 M10.9 M
Stock Based Compensation To Revenue 0.27  0.34 
Sales General And Administrative To Revenue 0.53  0.51 
Research And Ddevelopement To Revenue 2.00  1.90 
Capex To Revenue 0.03  0.03 
Revenue Per Share 2.58  1.36 
Ebit Per Revenue(1.15)(1.21)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY